Top Markets
Coin of the day
Qualigen Therapeutics, Inc. Qualigen Therapeutics, Inc.

Qualigen Therapeutics, Inc.

QLGN
Rankning i aktier #35381
Qualigen Therapeutics, Inc. is a biotechnology enterprise focused on advancing... Qualigen Therapeutics, Inc. is a biotechnology enterprise focused on advancing groundbreaking treatments for both cancer and infectious diseases. In addition to its developmental pipeline, the company offers FastPack, an efficient system designed for swift diagnostic testing. Its therapeutic candidates currently undergoing development include QN-302, an investigational compound targeting pancreatic ductal adenocarcinoma; QN-247, a DNA-coated gold nanoparticle formulated to combat various types of cancer; and RAS-F, a small-molecule inhibitor designed to block RAS oncogene protein-protein interactions, thereby impeding RAS mutations and suppressing tumor growth. The company is also progressing with the STARS blood cleansing system, an innovative DNA/RNA-based device engineered to purify a patient's bloodstream by eliminating tumor-derived substances and viruses. Founded in 1996, Qualigen Therapeutics, Inc. is headquartered in Carlsbad, California.
Aktiekurs
$2.37
Senast synkroniserad: 2025-12-15
Marknadsvärde
$3.99M
Förändring (1 dag)
-5.58%
Förändring (1 år)
24.74%
Land
US
Handel Qualigen Therapeutics, Inc. (QLGN)

Kategori

Historik för aktiesplit för Qualigen Therapeutics, Inc. (QLGN)
Aktien Qualigen Therapeutics, Inc. (symbol: QLGN) har genomgått totalt 0 aktiesplitar.
Den senaste spliten skedde den Aug 16, 2026.
En QLGN-aktie köpt före Aug 16, 2026 motsvarar nu 0 QLGN-aktier.
Lista över aktiesplitar
År Split Multipel Kumulativ multipel
Inte tillräckligt med data för de angivna datumen.
Aktiesplitar för liknande företag eller konkurrenter
Företag Antal aktiesplitar Kumulativ multipel Land
1 x2
US
0 -
NL
0 -
CH
0 -
KR
0 -
BE